| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |